Form 4: Edwards Lifesciences Executive Wayne Markowitz Sells Shares

Wayne Markowitz, a General Manager and Senior Vice President at Edwards Lifesciences, sold 583 shares of common stock at $73.27 per share on December 6, 2024.

Summary

• Wayne Markowitz, a General Manager and Senior Vice President at Edwards Lifesciences, sold 583 shares of the company's common stock on December 6, 2024.
• The sale was executed at a price of $73.27 per share.
• Following the transaction, Mr. Markowitz directly owns 9,493.8468 shares of Edwards Lifesciences common stock.
• The filing also notes that the form reflects changes in beneficial ownership and includes quarterly acquisitions of shares under the company's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing of an insider stock sale, which is neither positive nor negative in itself. It is a neutral event.

Industry Context

This is a routine Form 4 filing related to an insider transaction. Such filings are common and expected for executives of publicly traded companies.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The transaction is a relatively small sale of shares by an executive, which is not unusual and is similar to transactions seen at other comparable companies.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

Keywords

Edwards Lifesciences, insider trading, stock sale, Form 4, executive, Wayne Markowitz, share transaction, employee stock purchase plan